Amelioration of 2,4,6-trinitrobenzene sulphonic acid induced colitis in angiotensinogen knockout mice

Gut

Volumn 54, Issue 3, 2005, Pages 349-356

  Inokuchi, Y ^a   Morohashi, T ^a   Kawana, I ^a   Nagashima, Y ^a   Kihara, M ^a   Umemura, S ^a  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; LOSARTAN; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; HOMOZYGOSITY; IATROGENIC DISEASE; IMMUNE RESPONSE; INFLAMMATION; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROPHYLAXIS; PROTECTION; PROTEIN EXPRESSION; WILD TYPE;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSINOGEN; ANIMALS; COLITIS; COLON; CYTOKINES; IMMUNITY, MUCOSAL; INTESTINAL MUCOSA; LOSARTAN; MALE; MICE; MICE, INBRED ICR; MICE, KNOCKOUT; RENIN-ANGIOTENSIN SYSTEM; TRINITROBENZENESULFONIC ACID; WEIGHT LOSS;

EID: 14544296574     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2003.036343     Document Type: Article

References (42)

1. Levens NR. Local control of jejunal absorption by the renin-angiotensin system. J Cardiovasc Pharmacol 1986;8(suppl 10):S17-22.
2. Levens NR. Control of intestinal absorption by the renin-angiotensin system. Am J Physiol 1985;249:G3-15.
3. Rossig L, Dimmeler S, Zeiher AM. Apaptosis in the vascular wall and atherosclerosis. Basic Res Cardiol, 2001;96, 11-22.
4. Wesselman JP, De Mey JG. Angiotensin and cytoskeletal proteins: role in vascular remodeling. Curr Hypertens Rep, 2002;4, 63-70.
5. Wolf G, Wenzel U, Burns KD, et al. Angiotensin II activates nuclear transcription factor-κB through AT1 and AT2 receptors. Kidney Int, 2002;61, 1986-95.
6. Hisada Y, Sugaya T, Yamanouchi M, et al. Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. J Clin Invest 1999;103:627-35.
7. Ruiz-Ortega M, Bustos C, Hernandez-Presa MA, et al. Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-κB activation and monocyte chemoattractant protein-1 synthesis. J Immunol 1998;161:430-9.
8. Klahr S, Morrissey J. Angiotensin II and gene expression in kidney. Am J Kidney Dis 1998;31:171-6.
9. Kranzhofer R, Browatzki M, Schmidt J, et al. Angiotensin II activates the proinflammatory transcription factor nuclear factor-κB in human monocytes. Biochem Biophys Res Commun 1999;257:826-8.
10. Ruiz-Ortega M, Lorenzo O, Ruperez M, et al. Angiotensin II activates nuclear transcription factor κB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms. Circ Res 2000;86:1266-72.
11. 1 receptor. Nature 1995;375:247-50.
12. Bernstein K, Ali M, Sayeski P, et al. New insights into the cellular signaling of seven transmembrane receptors: the role of tyrosine phosphorylation. Lab Invest 1998;78:3-7.
13. Duff JL, Marrero MB, Paxton WG, et al. Angiotensin II signal transduction and the mitogen-activated protein kinase pathway. Carcdiovasc Res 1995;30:511-17.
14. Liu KD, Gaffen SL, Goldsmith MA. JAK/STAT signaling by cytokine receptors. Curr Opin Immunol 1998;10:271-8.
15. Suzuki Y, Gomez-Guerrero C, Shirato I, et al. Susceptibility to T cell-mediated injury in immune complex disease is linked to local activation of renin-angiotensin system: the role of NF-AT pathway. J Immunol 2002;169:4136-46.
16. Suzuki E, Nishimatsu H, Satonaka H, et al Angiotensin II induces myocyte enhancer factor 2- and calcineurin/nuclear factor of activated T cell-dependent transcriptional activation in vascular myocytes. Circ Res 2002;90:1004-11.
17. Nataraj C, Oliverio MI, Mannon RB, et al. Angiotensin II regulates cellular immune responses through a caldneurin-dependent pathway. J Clin Invest 1999;104:1693-701.
18. Fukuzawa M, Satoh J, Sagara M, et al. Angiotensin converting enzyme inhibitors suppress production of tumor necrosis factor-α in vitro and in vivo. Immunopharmacology 1997;36:49-55.
19. Andersson P, Cederholm T, Johansson AS, et al. Captopril-impaired production of tumor necrosis factor-α-induced interleukin-1 β in human monocytes is associated with altered intracellular distribution of nuclear factor-κB. J Lab Clin Med 2002;140:103-9.
20. Furukawa Y, Matsumori A, Hirozane T, et al. Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model. Circulation 1996;93:333-9.
21. Tanaka A, Matsumori A, Wang W, et al. An angiotensin II receptor antagonist reduces myocardial damage in an animal model of myocarditis. Circulation 1994;90:2051-5.
22. Amuchastegui SC, Azzollini N, Mister M, et al. Chronic allograft nephropathy in the rat is improved by angiotensin II receptor blockade but not by calcium channel antagonism. J Am Soc Nephrol 1998;9:1948-55.
23. Benediktsson H, Chea R, Davidoff A, et al. Antihypertensive drug treatment in chronic renal allograft rejection in the rat. Effect on structure and function. Transplantation 1996;62:1634-42.
24. Mackenzie HS, Ziai F, Nagano H, et al. Candesartan cilexetil reduces chronic renal allograft injury in Fisher-Lewis rats. J Hypertens Suppl 1997;15:521-5.
25. Campbell DJ, Habener JF. Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J Clin Invest 1986;78:31-9.
26. Paul M, Wagner J, Dzau VJ. Gene expression of the renin-angiotensin system in human tissues. Quantitative analysis by the palymerase chain reaction. J Clin Invest 1993;91:2058-64.
27. Phillips MI, Speakman EA, Kimura B. Levels of angiotensin and molecular biology of the tissue renin angiotensin systems. Regul Pept 1993;43:1-20.
28. Hirasawa K, Sato Y, Hosoda Y, et al. Immunohistochemical localization of angiotensin II receptor and local renin-angiotensin system in human colonic mucosa. J Histochem Cytochem 2002;50:275-82.
29. Elson CO, Sartor RB, Tennyson GS, et al. Experimental models of inflammatory bowel disease. Gastroenterology 1995;109:1344-67.
30. Tanimoto K, Sugiyama F, Goto Y, et al. Angiotensinogen-deficient mice with hypotension. J Biol Chem 1994;269:31334-7.
31. McCafferty DM, Miampamba M, Sihota E, et al. Role of inducible nitric oxide synthase in trinitrobenzene sulphonic acid induced colitis in mice. Gut 1999;45:864-73.
32. Massiera F, Seydoux J, Geloen A, et al. Angiotensinogen-deficient mice exhibit impairment of diet-induced weight gain with alteration in adipase tissue development and increased locomotor activity. Endocrinology 2001;142:5220-5.
33. Varesio L, Blasi E, Thurman GB, et al. Potent activation of mouse macrophages by recombinant interferon-gamma. Cancer Res 1984;44:4465-9.
34. Oswald IP, Gazzinelli RT, Sher A, et al. IL-10 synergizes with IL-4 and transforming growth factor-beta inhibit macrophage cytotoxic activity. J Immunol 1992;148:3578-82.
35. Gradman AH, Arcuri KE, Goldberg AI, et al. A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension. Hypertension, 1995;25:1345-50.
36. Ikeda LS, Harm SC, Arcuri KE, et al. Comparative antihypertensive effects of losartan 50 mg and losartan 50 mg titrated to 100 mg in patients with essential hypertension. Blood Press 1997;6:35-43.
37. Byyny RL. Antihypertensive efficacy of the angiotensin II AT1-receptor antagonist losartan: results of a randomized, double-blind, placebo-controlled, parallel-group trial using 24-hour blood pressure monitoring. Ambulatory Blood Pressure Monitoring Study Group. Blood Press Suppl 1996;2:71-7.
38. Dahlof B, Keller SE, Makris L, et al. Efficacy and tolerability of losartan potassium and atenolol in patients with mild to moderate essential hypertension. Am J Hypertens 1995;8:578-83.
39. Marohashi T, Iwabushi K, Watano K, et al. Allograft inflammatory factor-1 regulates trinitrobenzene sulphonic acid-induced colitis. Immunology 2003;110:112-19.
40. Fernandez-Castelo S, Arzt ES, Pesce A, et al. Angiotensin II regulates interferon-γ production. J Interferon Res 1987;7:261-8.
41. Shao J, Nangaku M, Miyata T, et al. Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury. Hypertension 2003;42:31-8.
42. Jaszewski R, Tolia V, Ehrinpreis MN, et al. Increased colonic mucosal angiotensin I and II concentrations in Crohn's colitis. Gastroenterology 1990;98:1543-8.